How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

230 results for

Pityriasis Rosea

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pityriasis rosea

Pityriasis rosea Pityriasis rosea - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Pityriasis rosea Last reviewed: February 2019 Last updated: March 2019 Summary An inflammatory skin disease with unclear aetiology, although an infectious cause has been suggested. Can present in patients of any age but most often in people aged 10 to 35 years. Manifests as an acute, self-limiting, inflammatory eruption characterised (...) by a single larger lesion, the herald patch, followed by eruption of smaller papulosquamous oval lesions. Spontaneous resolution, usually over several weeks, but can persist for up to 5 months. Symptoms treated by topical corticosteroids and/or oral antihistamines, or UV therapy. Definition Pityriasis rosea (PR) is an inflammatory skin condition of uncertain aetiology, although an unknown infectious agent has been suggested. PR manifests as an acute, self-limiting, inflammatory eruption characterised

2019 BMJ Best Practice

3. Pityriasis rosea

Pityriasis rosea Pityriasis rosea - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Pityriasis rosea Last reviewed: February 2019 Last updated: March 2019 Summary An inflammatory skin disease with unclear aetiology, although an infectious cause has been suggested. Can present in patients of any age but most often in people aged 10 to 35 years. Manifests as an acute, self-limiting, inflammatory eruption characterised (...) by a single larger lesion, the herald patch, followed by eruption of smaller papulosquamous oval lesions. Spontaneous resolution, usually over several weeks, but can persist for up to 5 months. Symptoms treated by topical corticosteroids and/or oral antihistamines, or UV therapy. Definition Pityriasis rosea (PR) is an inflammatory skin condition of uncertain aetiology, although an unknown infectious agent has been suggested. PR manifests as an acute, self-limiting, inflammatory eruption characterised

2017 BMJ Best Practice

4. Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? (Full text)

Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? 30246131 2018 11 14 2352-5126 4 8 2018 Sep JAAD case reports JAAD Case Rep Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? 800-801 10.1016/j.jdcr.2018.04.002 Drago Francesco F DISSAL Department of Dermatology, Policlinico San Martino, Genoa, Italy. Ciccarese Giulia G DISSAL Department of Dermatology, Policlinico San Martino, Genoa, Italy. Parodi Aurora A DISSAL Department of Dermatology (...) , Policlinico San Martino, Genoa, Italy. eng Journal Article 2018 09 14 United States JAAD Case Rep 101665210 2352-5126 HHV, human herpes virus PR, pityriasis rosea human herpes virus 6/7 ibrutinib pityriasis rosea pityriasis rosea–like eruption 2018 9 25 6 0 2018 9 25 6 0 2018 9 25 6 1 epublish 30246131 10.1016/j.jdcr.2018.04.002 S2352-5126(18)30101-2 PMC6142012 Int J Clin Pharm. 2015 Oct;37(5):739-43 26050251 J Am Acad Dermatol. 2014 Jan;70(1):196 24355268 JAAD Case Rep. 2017 Dec 19;4(1):55-57 29387749

2018 JAAD Case Reports PubMed

5. Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study. (Full text)

Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study. Pityriasis rosea is a common acute exanthema of unknown etiology, which causes severe anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our clinic between 2013 and 2017, were prospectively recorded. The patients with a confirmed pityriasis rosea diagnosis were followed up for 4 years in order to investigate the recurrence rate. Of the clinically suspected patients (...) , having a typical history of pityriasis rosea manifestations, a herald patch, and/or secondary colored squamous lesions, 400 were confirmed by biopsy to have pityriasis rosea. The 4-year follow-up was completed in 212 patients, of whom 136 (64.2%) were female and 76 (35.8%) were male. The recurrence rate was determined as 25.9% at the end of the 4-year follow-up period.

2019 Acta Dermato-Venereologica PubMed

6. Double blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low dose oral prednisolone in Pityriasis Rosea<sup/>. (PubMed)

Double blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low dose oral prednisolone in Pityriasis Rosea. To evaluate the efficacy and safety of short-course low-dose oral prednisolone in symptomatic pityriasis rosea (PR) of onset <5 days and compare it with placebo.Placebo-controlled randomized double-blind study design with the treatment group receiving tapering doses of oral prednisolone over 2 weeks and the control group receiving a placebo

2018 Journal of Dermatological Treatment

7. Pityriasis Rosea during Pregnancy: Major and Minor Alarming Signs. (PubMed)

Pityriasis Rosea during Pregnancy: Major and Minor Alarming Signs. Pityriasis rosea (PR) is a self-limiting exanthematous disease associated with human herpesvirus (HHV)-6 and/or HHV-7 reactivation. In pregnant women, PR may be associated with pregnancy complications.To determine relevant risk factors in the development of negative pregnancy outcome in PR.Between 2005 and 2017 at the Department of Dermatology, University of Genoa, we recruited 76 women who developed PR during pregnancy. In 60

2018 Dermatology

8. Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl. (PubMed)

Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl. Pityriasis rosea (PR) usually presents as acute exanthema with oval erythematous-squamous lesions localized on the trunk, arms, and legs with spontaneous remission. We present an unusual case of PR with frequent relapses during a period of 7 years. An 11-year-old white female patient presented with many pruritic erythematous oval lesions on her trunk. A second episode followed 2 years later with several pruritic

2018 Pediatrics

9. The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis. (PubMed)

The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis. Acyclovir has been reported as a potential therapy for pityriasis rosea (PR) in several clinical trials on the basis of evidence of the involvement of human herpes viruses 6 and 7.We evaluated the efficacy of acyclovir for abating PR skin lesions within a fixed period.We searched 4 databases for clinical trials that used oral acyclovir to treat PR and performed systematic review

2018 Journal of Dermatological Treatment

10. Pityriasis rosea in a patient with retrovirus infection: a reply (Full text)

Pityriasis rosea in a patient with retrovirus infection: a reply 29599683 2018 11 14 1642-395X 35 1 2018 Feb Postepy dermatologii i alergologii Postepy Dermatol Alergol Pityriasis rosea in a patient with retrovirus infection: a reply. 116-117 10.5114/ada.2018.73172 Ciccarese Giulia G Department of Dermatology, IRCCS A.O.U. San Martino-IST, Genoa, Italy. Parodi Aurora A Department of Dermatology, IRCCS A.O.U. San Martino-IST, Genoa, Italy. Drago Francesca F Department of Dermatology, IRCCS A.O.U

2018 Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii PubMed

11. Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis. (Full text)

Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis. Pityriasis rosea (PR), a skin rash, causes substantial discomfort in patients. There is a lack of effective therapies for PR. A combination of ultraviolet irradiation and indigo naturalis treatment has been shown to be a safe and effective regime for control of PR; however, the data have been largely inconsistent. Tis meta-analysis further evaluated

2018 Evidence-based Complementary and Alternative Medicine (eCAM) PubMed

12. Pityriasis rosea

Pityriasis rosea Pityriasis rosea - NICE CKS Share Pityriasis rosea: Summary Pityriasis rosea is a skin rash that is characterized by distinctive scaly, erythematous lesions. It is thought to be a reaction to exposure to infection. Pityriasis rosea mainly affects older children and young adults (commonly between 10 and 35 years of age), and is more common in women than men. The diagnosis of pityriasis rosea is clinical based on the appearance and distribution of the lesions: Discrete lesions (...) (ringworm) For most people with pityriasis rosea, no treatment is required. The rash may worsen before it resolves, with new crops of lesions continuing to appear for up to 6 weeks. It will usually settle without treatment within 2–3 months, but may take up to 5 months to disappear. After the rash has disappeared, there may be some hyperpigmentation or hypopigmentation of the affected skin for several months, but there should be no scarring. For people with itch, an emollient or a mild or moderately

2016 NICE Clinical Knowledge Summaries

13. Association of HLA-DQB1*03:03 with pityriasis rosea in Chinese patients. (PubMed)

Association of HLA-DQB1*03:03 with pityriasis rosea in Chinese patients. The association of human leucocyte antigen (HLA) with a variety of diseases has been described, especially with various autoimmune diseases. However, there are few studies on the association between HLA and pityriasis rosea (PR).To investigate the relevance of HLA II alleles with the development of PR.Typing for HLA-DRB1, HLA-DQA1 and HLA-DQB1 typing was performed in 55 patients with PR and 90 healthy controls (HCs), using

2017 Clinical & Experimental Dermatology

14. Oropharyngeal lesions in pityriasis rosea. (PubMed)

Oropharyngeal lesions in pityriasis rosea. Pityriasis rosea (PR) is an exanthematous disease associated with the endogenous systemic reactivation of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7). Oropharyngeal lesions may be associated with the exanthema, but anecdotal evidence suggests that few dermatologists are aware of their occurrence.Classifying oropharyngeal lesions in PR, establishing their prevalence, and assessing their possible association with different PR forms.The

2017 Journal of American Academy of Dermatology

15. Recurrent pityriasis rosea: A case report (Full text)

Recurrent pityriasis rosea: A case report Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either vaccine-induced stimulation of the immune system, or some rare vaccine component(influenza A [H1N1] vaccine, hepatitis B vaccine). We believe that such a case is unique and it has not been reported

2017 Human vaccines & immunotherapeutics PubMed

16. Scabies Surrepticius: Scabies Masquerading as Pityriasis Rosea (Full text)

Scabies Surrepticius: Scabies Masquerading as Pityriasis Rosea Scabies, a mite infestation caused by 'Sarcoptes scabiei', most commonly presents as pruritic linear burrows where the mite has invaded the skin. Scabies variant such as bullous, crusted, hidden, incognito, nodular and scalp-mimic the other conditions. In addition, atypical presentations of scabies can masquerade as dermatitis herpetiformis, ecchymosis, Langerhans cell histiocytosis, systemic lupus erythematosus, urticaria (...) , and urticaria pigmentosa. A 59-year-old male presented with non-pruritic papulosquamous plaques on his chest, abdomen, and back resembling lesions of pityriasis rosea in morphology and distribution. The complete cutaneous examination also demonstrated burrows on his finger webs. A mineral oil preparation of skin scrapings showed scabies mites, ova, and scybala. His infestation resolved after the treatment with topical permethrin 5% cream and oral ivermectin 15 mg on days one and eight. In conclusion

2017 Cureus PubMed

17. Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic (Full text)

Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic 28203625 2019 02 26 2352-5126 3 1 2017 Jan JAAD case reports JAAD Case Rep Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic. 78-81 10.1016/j.jdcr.2016.11.008 Bares Jennifer J Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama. Wang (...) , human herpes virus 8 IL, interleukin cutaneous plasmacytosis interleukin 6 multicentric Castleman disease pityriasis rosea plasmacytosis 2017 2 17 6 0 2017 2 17 6 0 2017 2 17 6 1 epublish 28203625 10.1016/j.jdcr.2016.11.008 S2352-5126(16)30140-0 PMC5294753 Dermatology. 1994;189(3):251-5 7949477 J Dermatol. 1980 Oct;7(5):341-9 7009684 Dermatology. 1995;190(3):242-4 7599390 Oncol Lett. 2016 Mar;11(3):1923-1925 26998101 Case Rep Dermatol Med. 2014;2014:840845 24839563 J Dermatol. 2016 Feb;43(2):229-30

2017 JAAD Case Reports PubMed

18. Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea (Full text)

Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea Pityriasis rosea (PR) is a common papulosquamous skin disease in which an infective agent may be implicated. Toll-like receptors (TLRs) play an important role in immune responses and in the pathophysiology of inflammatory skin diseases. Our aim was to determine the possible roles of TLRs 3, 7, 8, and 9 in the pathogenesis of PR.Twenty-four PR patients and 24 healthy individuals (as controls) were included in this case

2017 Journal of Pathology and Translational Medicine PubMed

19. Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus (Full text)

Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus 28670260 2018 11 13 1642-395X 34 3 2017 Jun Postepy dermatologii i alergologii Postepy Dermatol Alergol Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus. 276-278 10.5114/ada.2017.67850

2017 Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii PubMed

20. Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? (Full text)

Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? 28764276 2018 11 13 2249-782X 11 6 2017 Jun Journal of clinical and diagnostic research : JCDR J Clin Diagn Res Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? WL01 10.7860/JCDR/2017/27855.10050 Drago Francesco F Professor, Department of Dermatology, IRCSS AOU San Martino IST, Genoa, Italy. Ciccarese Giulia G PhD Student, Department of Dermatology, University

2017 Journal of clinical and diagnostic research : JCDR PubMed

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>